Immunoglobulins


Immunoglobulins are an important subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the field of immunology and pharmaceutical research. Also known as antibodies, immunoglobulins are proteins produced by the immune system to identify and neutralize foreign substances such as bacteria, viruses, and toxins.

These pharmaceutical APIs are extensively used in the development of various therapeutic products, including vaccines, immunotherapies, and diagnostic reagents. Immunoglobulins can be derived from different sources, such as human plasma, recombinant DNA technology, or hybridoma technology. Human plasma-derived immunoglobulins are obtained from pooled blood donations and undergo a rigorous purification process to ensure their safety and efficacy.

Immunoglobulins exhibit remarkable specificity and binding affinity towards their target antigens, making them ideal candidates for targeted therapies. They can be classified into different types, including IgG, IgM, IgA, IgD, and IgE, each with its unique functions and properties.

In pharmaceutical applications, immunoglobulins are employed for passive immunization, where they provide immediate protection against specific diseases by directly transferring antibodies to individuals. They can also be utilized for the treatment of autoimmune disorders, infectious diseases, and certain types of cancer.

The development and production of immunoglobulin APIs involve stringent quality control measures to ensure batch-to-batch consistency and adherence to regulatory guidelines. These APIs are characterized by various analytical techniques, including chromatography, electrophoresis, and spectroscopy, to assess their purity, potency, and structural integrity.

In summary, immunoglobulins are a vital subcategory of pharmaceutical APIs that hold immense potential for therapeutic and diagnostic applications. Their diverse range of functions and targeted specificity make them indispensable in the field of immunology and pharmaceutical research.

NameCAS number
Alpha-1-proteinase inhibitor9041-92-3
Eculizumab219685-50-4